The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Open accessAbstract
The MYC oncogene, which is frequently deregulated in human cancers, encodes a master transcription factor c-Myc (herein termed Myc) that integrates cell proliferation with metabolism through its regulation of thousands of genes including microRNAs (miRNA). In addition to its known function in regulating the cell cycle and glucose metabolism, recent studies document a role for Myc in stimulating glutamine catabolism, in part through the repression of miRNAs miR-23a and miR-23b. These observations suggest an additional level of complexity in tumor metabolism, which includes the commensal metabolic relationship between hypoxic and nonhypoxic regions of tumors as well as the surrounding stroma. Thus, a reevaluation of cancer metabolism considering glutamine catabolism with a better understanding of the tumor histological complexity is needed before cancer metabolism can be effectively targeted in therapy. Cancer Res; 70(3); 859–62
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, cancer cells driven by oncogenic MYC, K-Ras, and PIK3CA require glutamine for their survival and display extensive anabolic utilization of glutamine29,174,175”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Self-citationWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,233
Self-citationc-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Self-citationFlier, J. S., Mueckler, M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 783
Cited by
Sorted by citations
Items 201–300 of 381
Gonsalves, W. I., Jang, J. S., Jessen, E., Hitosugi, T., Evans, L. A., Jevremović, D., Pettersson, X.-M., Bush, A. G., Gransee, J., Anderson, E. I., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00235-4 · Cited by 34
Baba, S. K., Baba, S. K., Mir, R., Elfaki, I., Algehainy, N. A., Ullah, M. F., Barnawi, J., Altemani, F. H., Alanazi, M. A., Mustafa, S. K., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1164301 · Cited by 33
Chang, C., Zhang, C., Zhang, Q., Şahin, Ö., Wang, H., Xu, J., Xiao, Y. Q., Zhang, J., Rehman, S. K., Li, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9136 · Cited by 30
Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy
Chi, K.-H., Wang, Y., Huang, Y.-C., Chiang, H.-C., Chi, M., Chi, C., Wang, H.-E., & Kao, S.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.10873 · Cited by 30
Jiang, X., Ke, J., Jia, L., An, X., Ma, H., Li, Z., & Yuan, W. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04471-7 · Cited by 30
Wang, H., Lu, J. L., Stevens, T., Roberts, A., Mandel, J. A., Avula, R., Ma, B., Wu, Y. L., Wang, J., Land, C. V., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112830 · Cited by 28
From gametogenesis and stem cells to cancer: common metabolic themes
Pereira, S. L., Rodrigues, A. S., Sousa, M. I., Correia, M., Perestrelo, T., & Ramalho‐Santos, J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu034 · Cited by 33
Kleszcz, R., Paluszczak, J., Krajka‐Kuźniak, V., & Baer‐Dubowska, W. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/68979 · Cited by 29
PARP and other prospective targets for poisoning cancer cell metabolism
Michels, J., Obrist, F., Castedo, M., Vitale, I., & Kroemer, G. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.026 · Cited by 28
Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism
Kappler, M., Pabst, U., Weinholdt, C., Taubert, H. W., Rot, S., Kaune, T., Kotrba, J., Porsch, M., Güttler, A., Bache, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194742 · Cited by 29
Mitochondrial Changes in Cancer
Rao, S. G. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_40 · Cited by 30
McMahon, S. B. (2010) · Genes & Cancer · doi:10.1177/1947601910379011 · Cited by 28
Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
Pulito, C., Sanli, T., Rana, P., Muti, P. C., Blandino, G., & Strano, S. (2013) · Metabolites · doi:10.3390/metabo3041051 · Cited by 27
Polydatin alleviates parkinsonism in MPTP-model mice by enhancing glycolysis in dopaminergic neurons
Zhang, S., Wang, S., Shi, X., & Feng, X. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104815 · Cited by 27
Chung, S. H., Feldman, M. D., Martínez, D., Kim, H., Putt, M. E., Busch, D. R., Tchou, J. C., Czerniecki, B. J., Schnall, M. D., Rosen, M. A., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0578-z · Cited by 27
Optimization of Tumor Radiotherapy With Modulators of Cell Metabolism: Toward Clinical Applications
Danhier, P., Saedeleer, C. J. D., Karroum, O., Preter, G. D., Porporato, P. E., Jordan, B. F., Gallez, B., & Sonveaux, P. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.008 · Cited by 27
Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine
Xu, X., Zhu, H., Liu, F., Zhang, Y., Yang, J., Zhang, L., Zhu, L., Li, N., Kung, H. F., & Yang, Z. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002257 · Cited by 27
Roles of mitochondrial genetics in cancer metastasis
Welch, D. R., Foster, C., & Rigoutsos, I. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.07.004 · Cited by 26
Choi, H., Gupta, M., Sengupta, A., Furth, E. E., Hensley, C., Weljie, A. M., Lee, H. S., Lu, Y., Pantel, A., Mankoff, D. A., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101136 · Cited by 27
Mouhid, L., de Cedrón, M. G., García-Carrascosa, E., Reglero, G., Fornari, T., & de Molina, A. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214294 · Cited by 26
Weng, Q., Chen, M., Yang, W., Li, J., Fan, K., Xu, M., Weng, W., Lv, X., Fang, S., Zheng, L., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902895r · Cited by 26
Intermediary metabolism: An intricate network at the crossroads of cell fate and function
Ferreira, L. M. R., Li, A. M., Serafim, T. L., Sobral, M. C. M., Alpoim, M. C., & Urbano, A. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165887 · Cited by 27
Hyperthermia, the Tumor Microenvironment and Immunity
Calderwood, S. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-4694-7_2 · Cited by 26
Hong, D. K., Kho, A. R., Choi, B. Y., Lee, S. H., Jeong, J. H., Lee, S. H., Park, K., Park, J., & Suh, S. W. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00137 · Cited by 26
Otto, A. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596197 · Cited by 28
Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis
Pham, K., Maxwell, M. J., Sweeney, H., Alt, J., Rais, R., Eberhart, C. G., Slusher, B. S., & Raabe, E. H. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab018 · Cited by 26
Hyperglycemia-driven signaling bridges between diabetes and cancer
Ghareghomi, S., Arghavani, P., Mahdavi, M., Khatibi, A., García‐Jiménez, C., & Moosavi‐Movahedi, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116450 · Cited by 29
Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action
Talib, W. H., Baban, M. M., Bulbul, M. F., Al-Zaidaneen, E., Allan, A., Al-Rousan, E. W., Ahmad, R. H. Y., Alshaeri, H. K., Alasmari, M. M., & Law, D. S. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179593 · Cited by 25
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
Holly, J. M. P., Zeng, L., & Perks, C. M. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9445-5 · Cited by 27
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 27
Non-Hodgkin Lymphoma Metabolism
Kirsch, B. J., Chang, S., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_7 · Cited by 26
Sun, R., Li, X., Li, Y., Zhang, X., Li, X., Li, X., Shi, Z., & Bao, J. (2015) · Journal of Molecular Modeling · doi:10.1007/s00894-015-2675-4 · Cited by 24
c-MYC responds to glucose deprivation in a cell-type-dependent manner
Wu, S., Yin, X., Fang, X., Zheng, J., Li, L., Liu, X., & Chu, L. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.57 · Cited by 23
Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo
Schulte, M. I., Hight, M. R., Ayers, G. D., Liu, Q., Shyr, Y., Washington, M. K., & Manning, H. C. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-1008-z · Cited by 23
Liao, S., Liang, L., Yue, C., He, J., He, Z., Jin, X., Luo, G., & Zhou, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5040 · Cited by 22
Regulation of Glucose Metabolism in Hepatocarcinogenesis by MicroRNAs
Reyes, R., Motiwala, T., & Jacob, S. T. (2014) · Gene Expression · doi:10.3727/105221614x13919976902093 · Cited by 22
DNA Tumor Viruses and Cell Metabolism
Mushtaq, M., Darekar, S. D., & Kashuba, E. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6468342 · Cited by 24
Čuperlović‐Culf, M., Chute, I. C., Culf, A. S., Touaibia, M., Ghosh, A., Griffiths, S. G., Tulpan, D., Léger, S., Belkaid, A., Surette, M. E., et al. (2011) · Chemical Science · doi:10.1039/c1sc00382h · Cited by 20
Single-cell genomic analysis of head and neck squamous cell carcinoma
Stucky, A., Sedghizadeh, P. P., Mahabady, S., Chen, X., Zhang, C., Zhang, G., Zhang, X., & Zhong, J. F. (2017) · Oncotarget · doi:10.18632/oncotarget.18021 · Cited by 20
Elgamal, M. A., Khodeer, D. M., Abdel‐Wahab, B. A., Ibrahim, I. A. A., Alzahrani, A. R., Moustafa, Y. M., Ali, A. A., & El-Sayed, N. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1113966 · Cited by 19
The metabolic switch and its regulation in cancer cells
Zhou, S., Huang, C., & Wei, Y. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4041-1 · Cited by 21
Sato, M., Kawana, K., Adachi, K., Fujimoto, A., Yoshida, M., Nakamura, H., Nishida, H., Inoue, T., Taguchi, A., Ogishima, J., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.7388 · Cited by 20
Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.
Akiyama, Y., Iizuka, A., Kume, A., Komiyama, M., Urakami, K., Ashizawa, T., Miyata, H., Omiya, M., Kusuhara, M., & Yamaguchi, K. (2015) · PubMed · Cited by 20
Lewińska, A., Klukowska‐Rötzler, J., Deręgowska, A., Adamczyk‐Grochala, J., & Wnuk, M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101163 · Cited by 20
The role of PML in hematopoietic and leukemic stem cell maintenance
Nakahara, F., Weiss, C. N., & Ito, K. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1518-x · Cited by 18
The second genome: Effects of the mitochondrial genome on cancer progression
Scheid, A. D., Beadnell, T. C., & Welch, D. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.01.001 · Cited by 21
Is nuclear sirtuin SIRT6 a master regulator of immune function?
Pillai, V. B., & Gupta, M. P. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00483.2020 · Cited by 18
Questioning the preclinical paradigm: natural, extreme biology as an alternative discovery platform
Buffenstein, R., Nelson, O. L., & Corbit, K. C. (2014) · Aging · doi:10.18632/aging.100704 · Cited by 18
Heger, Z., Gumulec, J., Cernei, N., Polanska, H. H., Raudenská, M., Masařík, M., Eckschlager, T., Stiborová, M., Adam, V., & Kizek, R. (2016) · The Prostate · doi:10.1002/pros.23159 · Cited by 17
Li, Z., Zheng, W., Li, H., Li, C., & Gong, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132319 · Cited by 17
Jiang, Y., Qing, T., Qiao, X., Yang, Y., Chen, P., Han, M., Dong, K., Zhang, W., Xu, M., Wang, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508730 · Cited by 18
Liu, D., Wang, Y., Li, X., Wang, Y., Zhang, Z., Wang, Z., & Zhang, X. (2023) · Amino Acids · doi:10.1007/s00726-023-03316-y · Cited by 17
Foster, R. R., Griffin, S., Grooby, S., Feltell, R. E., Christopherson, C., Chang, M., Sninsky, J. J., Kwok, S., & Torrance, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045061 · Cited by 16
Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS
Bluestein, B. M., Morrish, F. M., Graham, D. J., Huang, L., Hockenbery, D. M., & Gamble, L. J. (2018) · Biointerphases · doi:10.1116/1.5038574 · Cited by 17
Alfaifi, A., Bahashwan, S., Alsaadi, M., Malhan, H. M., Aqeel, A., Al-Kahiry, W., Almehdar, H. A., & Qadri, I. (2022) · Diagnostics · doi:10.3390/diagnostics12020394 · Cited by 17
Bogen, K. T. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.10.017 · Cited by 16
Non-Hodgkin Lymphoma Metabolism
Kirsch, B. J., Chang, S., Betenbaugh, M. J., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_7 · Cited by 17
Lessons in aging from Myc knockout mouse models
Prochownik, E. V., & Wang, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1244321 · Cited by 16
Evans, L. A., Anderson, E. I., Jessen, E., Nandakumar, B. N., Atilgan, E., Jevremović, D., Hitosugi, T., Fonseca, R., Kumar, S. K., & Gonsalves, W. I. (2022) · American Journal of Hematology · doi:10.1002/ajh.26577 · Cited by 14
Ritorto, M. S., & Borlak, J. T. (2011) · Journal of Proteome Research · doi:10.1021/pr101207t · Cited by 14
Cellular energetics as a target for tumor cell elimination
Maximchik, P. V., Kulikov, A. V., Zhivotovsky, B., & Gogvadze, V. G. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020012 · Cited by 16
TIP30: A Novel Tumor-Suppressor Gene
Yu, X., Li, Z., & Wu, W. K. K. (2015) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14424348426116 · Cited by 14
Kocemba‐Pilarczyk, K. A., Dulińska-Litewka, J., Wojdyła, K. L., & Pękala, P. A. (2016) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1218187 · Cited by 14
Sato, M., Kawana, K., Adachi, K., Fujimoto, A., Taguchi, A., Fujikawa, T., Yoshida, M., Nakamura, H., Nishida, H., Inoue, T., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5398 · Cited by 14
Metabolic Profiling of Live Cancer Tissues Using NAD(P)H Fluorescence Lifetime Imaging
Blacker, T. S., Sewell, M. D. E., Szabadkai, G., & Duchen, M. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9027-6_19 · Cited by 14
Non-Coding RNAs Operate in the Crosstalk Between Cancer Metabolic Reprogramming and Metastasis
Li, Z., & Sun, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00810 · Cited by 14
Chang, C., Yeh, T., Chen, C., Wang, W.-P., Chen, Y.-T., Tsai, C., Chen, Y.-F., Ke, Y., Wang, J.-Y., Chen, C.-P., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0602 · Cited by 13
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Biomedicines · doi:10.3390/biomedicines9060619 · Cited by 12
He, Q., Shi, X., Zhang, L., Yi, C., Zhang, X., & Zhang, X. (2016) · Molecular Imaging · doi:10.1177/1536012116645440 · Cited by 13
Kou, F., Zhu, B., Zhou, W., Lv, C., Cheng, Y., & Wei, H. (2020) · Molecular Omics · doi:10.1039/d0mo00126k · Cited by 12
Targeting Altered Metabolism—Emerging Cancer Therapeutic Strategies
Seo, M., Crochet, R. B., & Lee, Y. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00014-0 · Cited by 13
Li, Y., Gao, H., Li, C., Han, X., & Qi, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.5440 · Cited by 12
Zhang, J., Zhu, Y., Dong, M., Yang, J. J., Weng, W.-W., & Teng, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.9346 · Cited by 12
Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma
Ding, L., & Liang, X. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100307 · Cited by 12
Coquery, N., Stupar, V., Farion, R., Maunoir-Regimbal, S., Barbier, E., Remy, C. C., & Fauvelle, F. (2015) · Metabolomics · doi:10.1007/s11306-015-0835-2 · Cited by 12
Liu, J., Zhu, Y. X., Wang, H., Han, C., Wang, Y., & Tang, R. (2024) · Cancer Science · doi:10.1111/cas.16049 · Cited by 11
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer
Martínez, I. P. V., Pérez‐Campos, E., Mayoral, L. P.-C., Cruz-Luis, H., Pina-Canseco, M. D. S., Zenteno, E., Salinas, I. L. B., Cruz, M. M., Mayoral, E. P., & Hernández‐Huerta, M. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189896 · Cited by 11
Gough, D. J., Sehgal, P. B., & Levy, D. E. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0891-8_6 · Cited by 11
Canceromics Studies Unravel Tumor’s Glutamine Addiction After Metabolic Reprogramming
Márquez, J., Matés, J. M., Alonso, F. J., Martín‐Rufián, M., Lobo, C., & Campos-Sandoval, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_12 · Cited by 11
Olawuni, B., & Bode, B. P. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00316.2024 · Cited by 10
Glutaminase catalyzes reaction of Glutamate to GABA
Nanga, R. P. R., DeBrosse, C., Singh, A. K., D’Aquilla, K., Hariharan, H., & Reddy, R. D. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.059 · Cited by 10
CD44-SLC1A2 Fusion Transcripts in Primary Colorectal Cancer
Shinmura, K., Kato, H., Igarashi, H., Inoue, Y., Nakamura, S., Du, C., Kurachi, K., Nakamura, T., Ogawa, H., Tanahashi, M., et al. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-014-9887-2 · Cited by 10
LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis
Yao, Y., Wang, H., & Li, B. (2014) · Tumor Biology · doi:10.1007/s13277-014-1903-3 · Cited by 10
Hainaut, P. L., Wiman, K. G., & Olivier, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8 · Cited by 10
Kim, H. M., & Koo, J. S. (2021) · Disease Markers · doi:10.1155/2021/8850990 · Cited by 10
Significance of low-carbohydrate diets and fasting in patients with cancer
Szypowska, A., & Regulska−Ilow, B. (2019) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2019.0083 · Cited by 10
Gaál, Z. (2021) · Biomolecules · doi:10.3390/biom11101531 · Cited by 9
Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks
Ghasemi, N., & Azizi, H. (2024) · Gene · doi:10.1016/j.gene.2024.148447 · Cited by 9
Hayat, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00001-9 · Cited by 10
Kou, F., Zhu, B., Zhou, W., Lv, C., Cheng, Y., & Wei, H. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114192 · Cited by 9
Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection
Gibson, M. S., Noronha-Estima, C., & Gama‐Carvalho, M. (2022) · Genes · doi:10.3390/genes13020273 · Cited by 9
Sex differences in gene regulatory networks during mid-gestational brain development
de Toledo, V. H. C., Feltrin, A. S., Barbosa, A. D. L., Tahira, A. C., & Brentani, H. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.955607 · Cited by 12
Clinical Implementation of Metabolomics
Imaizumi, A., Nishikata, N., Yoshida, H., Yoneda, J., Takahashi, S. T. M., Ando, T., Miyano, H., Nagao, K., Noguchi, Y., Shimba, N., et al. (2012) · InTech eBooks · doi:10.5772/33034 · Cited by 9
Pallotta, M. L. (2013) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1415-0 · Cited by 9
Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Shoshan, M. C. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030007 · Cited by 9
Lai, W.-T., Li, Y., Wu, S., Yang, C.-N., Wu, T., Wei, Y., & Deng, Y. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.04.003 · Cited by 9
Simulating Heterogeneous Tumor Cell Populations
Sundstrom, A., Bar‐Sagi, D., & Mishra, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168984 · Cited by 8
Presence of human breast cancer xenograft changes the diurnal profile of amino acids in mice
Paula, R., Sonehara, N. M., Jardim‐Perassi, B. V., Pál, Á., Asad, Y. J., Chuffa, L. G. D. A., Chammas, R. J., Raynaud, F. I., & Zuccari, D. A. P. D. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-04994-6 · Cited by 8
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors
Sui, Q., Yang, H., Hu, Z., Jin, X., Chen, Z., Jiang, W., & Sun, F. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03783-2 · Cited by 8
Higareda‐Almaraz, J. C., Valtierra-Gutiérrez, I. A., Hernández‐Ortíz, M., Contreras, S., Hernandez, E., & Encarnación‐Guevara, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065433 · Cited by 8
Metadata
- Authors
- Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Dang, Chi V.
- ORCID
- Dang, Chi V.
- Venue
- Cancer Research
- Published
- 2010-01-31
- Volume
- 70
- Issue
- 3
- Pages
- 859-862
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2818441
- OpenAlex
- W2070371419
- Cited by
- 379
- References
- 20
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 11 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 22 · 2019: 18 · 2018: 26 · 2017: 24 · 2016: 35 · 2015: 33 · 2014: 36 · 2013: 36 · 2012: 41
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 57341, R01CA057341, CA 51497, R37CA051497, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- Warburg effect, MYC oncogene, glutamine metabolism, glutamine catabolism, microRNA repression, miR-23a, miR-23b, cancer metabolism, tumor hypoxia, tumor stroma
- MeSH terms
- Animals, Citric Acid Cycle, Glucose, Glutamine, Humans, Mitochondria, Models, Biological, Neoplasms, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review